{
  "id": 7801471,
  "title": "Oncolytic virus-antibody combinations enhance immune-mediated killing of osteosarcoma",
  "url": "https://urgent.news/2026/09/16/oncolytic-virus-antibody-combinations-enhance-immune-mediated-killing",
  "topic": "world",
  "section": "World",
  "published": "2026-09-16T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.09.10.750740v1?rss=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "A major barrier to effective immunotherapy in osteosarcoma (OS) is the highly immunosuppressive tumour microenvironment (TME), which limits immune recognition and elimination of tumour cells. We evaluated a panel of oncolytic herpes simplex viruses (oHSVs) for their direct oncolytic activity, immune-modulatory properties and capacity to counteract OS-associated immunosuppression using…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}